MedTrace Logo

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

NCT04490434 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-07-29

No results posted yet for this study

Summary

drug-drug interaction between DWP14012 and three different kinds of NSAIDs

Conditions

  • Healthy Male Volunteers

Interventions

DRUG

DWP14012

DWP14012 40mg, bid

DRUG

Celecoxib

Celecoxib 200mg, bid

DRUG

Naproxen

Naproxen 500mg, bid

DRUG

Meloxicam

Meloxicam 15mg, qd

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Principal Investigators

  • Jang In-Jin, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2020-08-31
Completion
2020-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04490434 on ClinicalTrials.gov